GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.

Graminex^®, L.L.C. is pleased to announce publication of a peer reviewed clinical study with Graminex^® Flower Pollen Extract for women’s urinary incontinence and urinary health in Current Urology. The study was conducted as a randomized, double-blind, placebo-controlled study to investigate the effectiveness of Graminex^® Flower Pollen Extracts in 114 healthy women with urinary incontinence. It was concluded that significant and meaningful reductions in UI severity were found in the Graminex^® RCT Fem™ UI study group along with significant improvement in stress-induced urinary leakage volume with the PollenBerry^® study group. A full version is available at: Current Urology - Original Article

“Many women experience urinary incontinence throughout their lives during postpartum, menopause, and the natural aging process. There is limited natural support to help improve the symptoms of urinary incontinence currently on the market. With this peer reviewed publication, Graminex is excited to offer a natural product to help improve women’s lives, when it’s needed most,” said Colleen May, CBO.

About Graminex ^® , L.L.C.

Graminex^®,L.L.C. is the leading producer of natural and non-solvent Graminex^® Flower Pollen Extract™. Graminex^® directly owns and manages more than 6,500 acres of farmland in Northwest Ohio to meet its customer’s needs. Graminex’s active ingredients are grown and processed for the dietary supplement, nutraceutical, pharmaceutical, food and skin care industries. Graminex^® markets its own branded line of raw materials and dietary supplements, focusing on prostate care, urinary care, menopausal support, and skin care.

For further information please contact Graminex^®,L.L.C., Colleen May at +1 (419) 278-1023 or by e-mail at graminex@graminex.com. You may also visit www.graminex.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240513362788/en/

Contact information

Colleen E. May
Chief Business Officer
bugs@graminex.com
+1 (419) 278-1023